The quarterly doesn't usually come with an activities report,...

The quarterly doesn't usually come with an activities report, unlike miners. And, in case you are unaware; the HCV compound is 225, so I doubt there will news about the compound. Unless they resurrect BIT314, which was touted to be much stronger against HCV. There may be news about an agreement to further trial it in Asia (HCV), with a potential partner. At one stage, they were looking to get this going with a possible cornerstone investor. I had expected news on this by now....... but I'm not that interested in BIT225 for HCV. I may take any announcement about this as a chance to unload into the excitement that will be generated.